Current and future threats to global biosecurity are predominantly due to infectious pathogens. Our platform technology of molecules bind to DNA at multiple sites to kill pathogens of many different infectious disease types including bacteria, fungi, viruses and parasites, with a unique mechanism of action to delay resistance development.
Primary Application Area: Biotech, Pharma, Health
Technology Development Status: Prototype
Technology Readiness Level: TRL 4
Vetted Programs/Awards: £20k INSPIRE 100 award out of the University of Strathclyde for the most 'investable' spin out company.
Organization Type: Early-stage Startup (Seed)
Showcase Booth #: M59
Market Keywords: Infection, fungal, resistance